AegerionPharmaceuticals is a Novelion Therapeutics Inc. company: a biopharmaceutical company dedicated to developing and commercialising innovative new therapies for individuals living with rare and orphan diseases. Aegerion was acquired by Novelion Therapeutics Inc. in November 2016. The company's European headquarters are situated in Windsor, UK. This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
View Top Employees from Aegerion Pharmaceuticals, Inc.| Website | http://www.aegerion.com |
| Ticker | NASDAQ:AEGR |
| Revenue | $239 million |
| Funding | $47.5 million |
| Employees | View employees |
| Founded | 2005 |
| Address | 101 Main St, Ste 1850, Cambridge, Massachusetts 02142, US |
| Phone | (617) 500-7867 |
| Fax | (617) 945-7968 |
| Technologies | |
| Industry | Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Therapeutics |
| Competitors | Adamas Pharmaceuticals, Inc., Aquinox Pharmaceuticals, Inc., Corcept Therapeutics, Proteostasis Therapeutics, Inc. (PTI), Raptor Pharmaceuticals |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325412 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Aegerion Pharmaceuticals, Inc. employee's phone or email?
Aegerion Pharmaceuticals, Inc. Questions
The Aegerion Pharmaceuticals, Inc. annual revenue was $239 million in 2023.
Aegerion Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
The NAICS codes for Aegerion Pharmaceuticals, Inc. are [325412, 3254, 32541, 32, 325].
The SIC codes for Aegerion Pharmaceuticals, Inc. are [283, 28].
